<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01348321</url>
  </required_header>
  <id_info>
    <org_study_id>Acne and levamisole</org_study_id>
    <secondary_id>126/Ø¯</secondary_id>
    <nct_id>NCT01348321</nct_id>
  </id_info>
  <brief_title>Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne</brief_title>
  <official_title>Superior Efficacy of Azithromycin and Levamisole Versus of Azithromycin Alone in the Treatment of Inflammatory Acne Vulgaris: An Investigator Blind Randomized Clinical Trial on 169 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahvaz Jundishapur University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ahvaz Jundishapur University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different immunologic mechanisms contribute to development of inflammation in acne vulgaris
      and immunologic effect of levamisole has been demonstrated.

      Objective: The aim of this study was to compare azithromycin and levamisole with azithromycin
      alone in the treatment of acne vulgaris.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An investigator blind clinical randomized prospective two months study was designed. One
      hundred sixty nine acne patients presenting in our outpatients clinic were randomly allocated
      to two treatment groups: azithromycin and levamisole ( group 1 ) and azithromycin alone (
      group 2 ) .One hundred forty eight patients completed the duration of the study and their
      clinical responses were evaluated and compared by using monthly photographic records .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>one year</time_frame>
    <description>A questionnaire was filled for every patient.For patients in both groups, lab tests were done at each visit.All adverse effect and the number of them were recorded and the patients who had side-effects or didn't follow the visits were excluded from the study.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">169</enrollment>
  <condition>Acne</condition>
  <arm_group>
    <arm_group_label>Azithromicine plus levamisole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Azithromicin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levamisole</intervention_name>
    <description>Group 1: Azithromycin 500 mg per day, three days a week plus oral levamisole 150 mg per day, two days a week. Group 2: Azithromycin 500 mg per day, three days a week. The used medications were not revealed to their physician. A questionnaire was filled for every patient and photos were taken from lesions using a digital camera at first, second and final visit.</description>
    <arm_group_label>Azithromicine plus levamisole</arm_group_label>
    <arm_group_label>Azithromicin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who had at least 20 papules and/or pustules,

          2. Patients with nodule and/or cyst disregarding the number of papules of pustules, were
             included the study. There was not any age limit

        Exclusion Criteria:

          1. were using any type of systemic treatment for their acne at the time of visit or
             during the last month;

          2. had any hematological, renal or hepatic disease

          3. were pregnant or lactating;

          4. had drug-induced acne;

          5. were using alcohol, anti-convulsants or anti-coagulants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sima Rasaii, Dermtologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jundishapur University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azadegan Street,Imam Hospital,Department of Dermatology</name>
      <address>
        <city>Ahvaz</city>
        <state>Khoozestan</state>
        <zip>6193673166</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Haneke E. [Levamisole treatment of acne fulminans (author's transl)]. Z Hautkr. 1981 Sep 1;56(17):1160-6. German.</citation>
    <PMID>6457452</PMID>
  </reference>
  <results_reference>
    <citation>Ansarin H, Savabynasab S, Behzadi AH, Sadigh N, Hasanloo J. Doxycycline plus levamisole: combination treatment for severe nodulocystic acne. J Drugs Dermatol. 2008 Aug;7(8):737-40.</citation>
    <PMID>18720689</PMID>
  </results_reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2011</study_first_submitted>
  <study_first_submitted_qc>May 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2011</study_first_posted>
  <last_update_submitted>May 4, 2011</last_update_submitted>
  <last_update_submitted_qc>May 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Sima Rasaii</name_title>
    <organization>Jundishapur University of Medical Sciences</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levamisole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

